drugset / Trial / NCT00832520

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

NCT00832520

Phase 2 Terminated 13 enrolled New Mexico Cancer Research Alliance
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to find out if remeron, also called mirtazapine, can help you prevent weight loss while on treatment for your cancer. Remeron is currently used to treat depression and has not been approved by the Food and Drug Administration for use to treat weight loss.

Timeline

Start
2008-11
Primary completion
2010-07
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirtazapine Other / unclassified 7.5 mg Oral
Subject Mirtazapine Other / unclassified 15 mg Oral